Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Some medications and supplements can affect male fertility, with some improving and others harming sperm quality.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Biological therapy boosts the immune system to effectively fight melanoma.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

The patches could quickly deliver epilepsy treatment and reduce seizures.

JAK inhibitors show promise for treating various skin diseases.

Tadalafil and Finasteride may help treat aggressive melanoma.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.